期刊文献+

PIWIL1在肝细胞癌中的表达及临床意义 被引量:5

Clinical significance of expression of PIWIL1 protein in hepatocellular carcinoma
下载PDF
导出
摘要 目的:探讨干细胞相关蛋白PIWI样蛋白1(PIWI-like protein-1,PIWIL1)在肝细胞癌组织中的表达及临床意义,并探索其表达与患者预后的关系.方法:应用免疫组织化学检测47例肝细胞癌标本中PIWIL1的表达,免疫印迹(Western blot)法检测31例肝细胞癌组织中PIWIL1的表达,分析PIWIL1表达与临床特征及预后的关系.结果:PIWIL1在肝癌组织中高表达,在正常肝组织中低表达,PIWIL1同肿瘤分化程度、有无临近组织侵犯有关,与肿瘤大小及甲胎蛋白(α-fetoprotein,AFP)水平无关;其阳性表达预示患者预后较差.结论:PIWIL1的高表达同病理分化程度、临近组织侵犯相关及患者预后相关. AIM: To discuss the clinical significance of positive expression of PIWI-like protein-1 (PIWIL1) in hepatocellular carcinoma (HCC). METHODS: Immunohistochemistry was used to detect the expression of PIWIL1 in 47 cases of HCC and matched tumor-adjacent hepatic tissues. Western blot was used to detect the expression of PIWIL1 in 31 fresh HCC tissues and matched tumor-adjacent hepatic tissues. The relationship between PIWIL1 positive expression and clinical features or prognosis of HCC patients was analyzed. RESULTS: The positive rate of PIWIL1 expression was significantly higher in HCC than in normal liver tissue (P 〈 0.05). PIWIL1 expression was positively correlated with the invasion to the adjacent tissue and the histological differentiation (both P 〈 0.05). PIWIL1 positive cases had a poor prognosis. CONCLUSION: The high expression of PIWIL1 is related to pathological differentiation and the invasion to the adjacent tissue, as well as to the prognosis of HCC patients.
出处 《世界华人消化杂志》 CAS 北大核心 2014年第1期119-124,共6页 World Chinese Journal of Digestology
关键词 肝细胞癌 PIWIL1 预后 Hepatocellular carcinoma PIWI-like protein-1 Prognosis
  • 相关文献

参考文献13

二级参考文献60

共引文献471

同被引文献53

  • 1张兰,张德志.天胡荽的研究进展[J].现代食品与药品杂志,2007,17(1):15-17. 被引量:28
  • 2Thomas M.Molecular targeted therapy for hepatocellular carcinoma[J].J Gastroenterol,2009,44(Suppl 19):136-141.
  • 3Andree C,Schmidt VJ,Munder BI,et al.Detecting of breast cancer metastasis by means of regional lymph node sampling during autologous breast reconstruction-a screening of 519 consecutive patients[J].Med Sci Monit,2012,18(10):605-610.
  • 4Schacht V,Dadras SS,Johnson LA,et al.Up-regulation of the lymphatic marker podoplanin,a mucin-type transmembrane glycoprotein,in human squamous cell carcinomas and germ cell tumors[J].Am J Pathol,2005,166(3):913-921.
  • 5Wetterwad A,Hofstetter W,Cecchini MG,et al.Charact- erization and cloning of the El I antigen,a marker expressed by rat osteoblasts and osteocytes[J].Bone,1996,18(2):125-132.
  • 6Vanderbilt JN,Dobbs LG.Characterization of the gene and promoter for RTI40,a differentiation marker of type I alveolar cells[J].Am J Respir Cell Mol Biol,1998,19(4):662-671.
  • 7Suurmeijer AJ,Fletcher CD.Papillary haemangioma.A distinctive cutaneous haemangioma of the head and neck area containing eosinophilic hyaline globules[J].Histopathology,2007,51(5):638-648.
  • 8Tateyama H,Sugiura H,Yamatani C,et al.Expression of podoplanin in thymoma:its correlation with tumor invasion,nodal metastasis,and poor clinical outcome[J],Hum Pathol,2011,42(4);533-540.
  • 9KatoY,Kaneko MK,Kuno A,et al.Inhibition of tumor cell-induced platelet aggregation using a novel anti- podoplanin antibody reacting with its platelet- aggregation-stimulating domain[J].Biochem Biophys Res Commun,2006,349(4):1301-1307.
  • 10田瑞卿,刘民,李欣,汤华.PIWIL1在不同肿瘤细胞中的差异性表达[J].中国生物化学与分子生物学报,2008,24(11):1072-1075. 被引量:10

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部